Epstein-Barr virus latent membrane protein 1 represses DNA repair through the PI3K/Akt/FOXO3a pathway in human epithelial cells

Journal of Virology

Volumn 82, Issue 16, 2008, Pages 8124-8137

  Chen, Yi Ren ^a   Liu, Ming Tsan ^c   Chang, Yu Ting ^b   Wu, Chung Chun ^b   Hu, Chi Yuan ^b   Chen, Jen Yang ^a,b  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^b NATIONAL HEALTH RESEARCH INSTITUTES   (Taiwan)

^c CENTER FOR DISEASE CONTROL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

DNA (APURINIC OR APYRIMIDINIC SITE) LYASE; DNA BINDING PROTEIN; LATENT MEMBRANE PROTEIN 1; NUCLEOTIDE; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; TRANSCRIPTION FACTOR FKHRL1; VIRUS PROTEIN;

ARTICLE; DNA REPAIR; ENZYME PHOSPHORYLATION; EPITHELIUM CELL; EPSTEIN BARR VIRUS; EXCISION REPAIR; GENOMIC INSTABILITY; HUMAN; HUMAN CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; TRANSCRIPTION INITIATION;

1-PHOSPHATIDYLINOSITOL 3-KINASE; CELL LINE, TUMOR; CELL NUCLEUS; CYTOSOL; DNA REPAIR; DNA-BINDING PROTEINS; EPITHELIAL CELLS; FORKHEAD TRANSCRIPTION FACTORS; GENE EXPRESSION REGULATION, VIRAL; HUMANS; MODELS, BIOLOGICAL; PLASMIDS; PROTEIN STRUCTURE, TERTIARY; PROTO-ONCOGENE PROTEINS C-AKT; VIRAL MATRIX PROTEINS;

HUMAN HERPESVIRUS 4;

EID: 49149121718     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.00430-08     Document Type: Article

References (69)

1. Arden, K. C. 2006. Multiple roles of FOXO transcription factors in mammalian cells point to multiple roles in cancer. Exp. Gerontol. 41:709-717.
2. Atkinson, P. G., H. J. Coope, M. Rowe, and S. C. Ley. 2003. Latent membrane protein 1 of Epstein-Barr virus stimulates processing of NF-κB2 p100 to p52. J. Biol. Chem. 278:51134-51142.
3. Bader, A. G., S. Kang, L. Zhao, and P. K. Vogt. 2005. Oncogenic PI3K deregulates transcription and translation. Nat. Rev. Cancer 5:921-929.
4. Baichwal, V. R., and B. Sugden. 1988. Transformation of BALB 3T3 cells by the BNLF-1 gene of Epstein-Barr virus. Oncogene 2:461-467.
5. Brinkmann, M. M., and T. F. Schulz. 2006. Regulation of intracellular signalling by the terminal membrane proteins of members of the Gammaherpesvirinae. J. Gen. Virol. 87:1047-1074.
6. Chu, G., and E. Chang. 1988. Xeroderma pigmentosum group E cells lack a nuclear factor that binds to damaged DNA. Science 242:564-567.
7. Dawson, C. W., A. B. Rickinson, and L. S. Young. 1990. Epstein-Barr virus latent membrane protein inhibits human epithelial cell differentiation. Nature 344:777-780.
8. Dawson, C. W., G. Tramountanis, A. G. Eliopoulos, and L. S. Young. 2003. Epstein-Barr virus latent membrane protein 1 (LMP1) activates the phosphatidylinositol 3-kinase/Akt pathway to promote cell survival and induce actin filament remodeling. J. Biol. Chem. 278:3694-3704.
9. Devergne, O., E. Hatzivassiliou, K. M. Izumi, K. M. Kaye, M. F. Kleijnen, E. Kieff, and G. Mosialos. 1996. Association of TRAF1, TRAF2, and TRAF3 with an Epstein-Barr virus LMP1 domain important for B-lymphocyte transformation: role in NF-κB activation. Mol. Cell. Biol. 16:7098-7108.
10. Dirmeier, U., B. Neuhierl, E. Kilger, G. Reisbach, M. L. Sandberg, and W. Hammerschmidt. 2003. Latent membrane protein 1 is critical for efficient growth transformation of human B cells by Epstein-Barr virus. Cancer Res. 63:2982-2989.
11. Duensing, S., and K. Munger. 2002. The human papillomavirus type 16 E6 and E7 oncoproteins independently induce numerical and structural chromosome instability. Cancer Res. 62:7075-7082.
12. Eliopoulos, A. G., S. M. Blake, J. E. Floettmann, M. Rowe, and L. S. Young. 1999. Epstein-Barr virus-encoded latent membrane protein 1 activates the JNK pathway through its extreme C terminus via a mechanism involving TRADD and TRAF2. J. Virol. 73:1023-1035.
13. Eliopoulos, A. G., J. H. Caamano, J. Flavell, G. M. Reynolds, P. G. Murray, J. L. Poyet, and L. S. Young. 2003. Epstein-Barr virus-encoded latent infection membrane protein 1 regulates the processing of p100 NF-κB2 to p52 via an IKKγ/NEMO-independent signalling pathway. Oncogene 22:7557-7569.
14. Eliopoulos, A. G., M. Stack, C. W. Dawson, K. M. Kaye, L. Hodgkin, S. Sihota, M. Rowe, and L. S. Young. 1997. Epstein-Barr virus-encoded LMP1 and CD40 mediate IL-6 production in epithelial cells via an NF-κB pathway involving TNF receptor-associated factors. Oncogene 14:2899-2916.
15. Eliopoulos, A. G., and L. S. Young. 1998. Activation of the cJun N-terminal kinase (JNK) pathway by the Epstein-Barr virus-encoded latent membrane protein 1 (LMP1). Oncogene 16:1731-1742.
16. Eliopoulos, A. G., and L. S. Young. 2001. LMP1 structure and signal transduction. Scmin. Cancer Biol. 11:435-444.
17. Fahraeus, R., L. Rymo, J. S. Rhim, and G. Klein. 1990. Morphological transformation of human keratinocytes expressing the LMP gene of Epstein-Barr virus. Nature 345:447-449.
18. Franken, M., O. Devergne, M. Rosenzweig, B. Annis, E. Kieff, and F. Wang. 1996. Comparative analysis identifies conserved tumor necrosis factor receptor-associated factor 3 binding sites in the human and simian Epstein-Barr virus oncogene LMP1. J. Virol. 70:7819-7826.
19. Fujiwara, Y., C. Masutani, T. Mizukoshi, J. Kondo, F. Hanaoka, and S. Iwai. 1999. Characterization of DNA recognition by the human UV-damaged DNA-binding protein. J. Biol. Chem. 274:20027-20033.
20. Furnari, F. B., H. J. Huang, and W. K. Cavenee. 1998. The phosphoinositol phosphatase activity of PTEN mediates a serum-sensitive G1 growth arrest in glioma cells. Cancer Res. 58:5002-5008.
21. Gires, O., U. Zimber-Strobl, R. Gonnella, M. Ueffing, G. Marschall, R. Zeidler, D. Pich, and W. Hammerschmidt. 1997. Latent membrane protein 1 of Epstein-Barr virus mimics a constitutively active receptor molecule. EMBO J. 16:6131-6140.
22. Greer, E. L., and A. Brunet. 2005. FOXO transcription factors at the interface between longevity and tumor suppression. Oncogene 24:7410-7425.
23. Hoeijmakers, J. H. 2001. Genome maintenance mechanisms for preventing cancer. Nature 411:366-374.
24. Huen, D. S., S. A. Henderson, D. Croom-Carter, and M. Rowe. 1995. The Epstein-Barr virus latent membrane protein-1 (LMP1) mediates activation of NF-κB and cell surface phenotype via two effector regions in its carboxyterminal cytoplasmic domain. Oncogene 10:549-560.
25. Hwang, J. K., and C. T. Lin. 1997. Co-localization of endogenous and exogenous p53 proteins in nasopharyngeal carcinoma cells. J. Histochem Cytochem. 45:991-1003.
26. Izumi, K. M., K. M. Kaye, and E. D. Kieff. 1997. The Epstein-Barr virus LMP1 amino acid sequence that engages tumor necrosis factor receptor associated factors is critical for primary B lymphocyte growth transformation. Proc. Natl. Acad. Sci. USA 94:1447-1452.
27. Izumi, K. M., and E. D. Kieff. 1997. The Epstein-Barr virus oncogene product latent membrane protein 1 engages the tumor necrosis factor receptor-associated death domain protein to mediate B lymphocyte growth transformation and activate NF-κB. Proc. Natl. Acad. Sci. USA 94:12592-12597.
28. Kao, S. Y., and S. J. Marriott. 1999. Disruption of nucleotide excision repair by the human T-cell leukemia virus type 1 Tax protein. J. Virol. 73:4299-4304.
29. Kaye, K. M., K. M. Izumi, and E. Kieff. 1993. Epstein-Barr virus latent membrane protein 1 is essential for B-lymphocyte growth transformation. Proc. Natl. Acad. Sci. USA 90:9150-9154.
30. Kaye, K. M., K. M. Izumi, H. Li, E. Johannsen, D. Davidson, R. Longnecker, and E. Kieff. 1999. An Epstein-Barr virus that expresses only the first 231 LMP1 amino acids efficiently initiates primary B-lymphocyte growth transformation. J. Virol. 73:10525-10530.
31. Keeney, S., G. J. Chang, and S. Linn. 1993. Characterization of a human DNA damage binding protein implicated in xeroderma pigmentosum E. J. Biol. Chem. 268:21293-21300.
32. Kieser, A., E. Kilger, O. Gires, M. Ueffing, W. Kolch, and W. Hammerschmidt. 1997. Epstein-Barr virus latent membrane protein-1 triggers AP-1 activity via the c-Jun N-terminal kinase cascade. EMBO J. 16:6478-6485.
33. Kino, T., M. U. De Martino, E. Charmandari, T. Ichijo, T. Outas, and G. P. Chrousos. 2005. HIV-1 accessory protein Vpr inhibits the effect of insulin on the FOXO subfamily of forkhcad transcription factors by interfering with their binding to 14-3-3 proteins: potential clinical implications regarding the insulin resistance of HIV-1-infected patients. Diabetes 54:23-31.
34. Kulwichit, W., R. H. Edwards, E. M. Davenport, J. F. Baskar, V. Godfrey, and N. Raab-Traub. 1998. Expression of the Epstein-Barr virus latent membrane protein 1 induces B-cell lymphoma in transgenic mice. Proc. Natl. Acad. Sci. USA 95:11963-11968.
35. Lee, T. H., S. J. Elledge, and J. S. Butel. 1995. Hepatitis B virus X protein interacts with a probable cellular DNA repair protein. J. Virol. 69:1107-1114.
36. Lin, C. T., W. Y. Chan, W. Chen, H. M. Huang, H. C. Wu, M. M. Hsu, S. M. Chuang, and C. C. Wang. 1993. Characterization of seven newly established nasopharyngeal carcinoma cell lines. Lab. Investig. 68:716-727.
37. Lin, C. T., C. I. Wong, W. Y. Chan, K. W. Tzung, J. K. Ho, M. M. Hsu, and S. M. Chuang. 1990. Establishment and characterization of two nasopharyngeal carcinoma cell lines. Lab. Investig. 62:713-724.
38. Lin, G. Y., R. G. Paterson, C. D. Richardson, and R. A. Lamb. 1998. The V protein of the paramyxovirus SV5 interacts with damage-specific DNA binding protein. Virology 249:189-200.
39. Liu, M. T., Y. T. Chang, S. C. Chen, Y. C. Chuang, Y. R. Chen, C. S. Lin, and J. Y. Chen. 2005. Epstein-Barr virus latent membrane protein 1 represses p53-mediated DNA repair and transcriptional activity. Oncogene 24:2635-2646.
40. Liu, M. T., Y. R. Chen, S. C. Chen, C. Y. Hu, C. S. Lin, Y. T. Chang, W. B. Wang, and J. Y. Chen. 2004. Epstein-Barr virus latent membrane protein 1 induces micronucleus formation, represses DNA repair and enhances sensitivity to DNA-damaging agents in human epithelial cells. Oncogene 23:2531-2539.
41. Lovejoy, C. A., K. Lock, A. Yenamandra, and D. Cortez. 2006. DDB1 maintains genome integrity through regulation of Cdt1. Mol. Cell. Biol. 26:7977-7990.
42. Luftig, M., T. Yasui, V. Soni, M. S. Kang, N. Jacobson, E. Cahir-McFarland, B. Seed, and E. Kieff. 2004. Epstein-Barr virus latent infection membrane protein 1 TRAF-binding site induces NIK/IKK alpha-dependent noncanonical NF-κB activation. Proc. Natl. Acad. Sci. USA 101:141-146.
43. Mainou, B. A., D. N. Everly, Jr., and N. Raab-Traub. 2005. Epstein-Barr virus latent membrane protein 1 CTAR1 mediates rodent and human fibroblast transformation through activation of PI3K. Oncogene 24:6917-6924.
44. Majone, F., O. J. Semmes, and K. T. Jeang. 1993. Induction of micronuclei by HTLV-1 Tax: a cellular assay for function. Virology 193:456-459.
45. Man, C., J. Rosa, L. T. Lee, V. H. Lee, B. K. Chow, K. W. Lo, S. Doxsey, Z. G. Wu, Y. L. Kwong, D. Y. Jin, A. L. Cheung, and S. W. Tsao. 2007. Latent membrane protein 1 suppresses RASSF1A expression, disrupts microtubule structures and induces chromosomal aberrations in human epithelial cells. Oncogene 26:3069-3080.
46. Mitsudomi, T., S. M. Steinberg, M. M. Nau, D. Carbone, D. D'Amico, S. Bodner, H. K. Oie, R. I. Linnoila, J. L. Mulshine, J. D. Minna, et al. 1992. p53 gene mutations in non-small-cell lung cancer cell lines and their correlation with the presence of ras mutations and clinical features. Oncogene 7:171-180.
47. Morrison, J. A., M. L. Gulley, R. Pathmanathan, and N. Raab-Traub. 2004. Differential signaling pathways are activated in the Epstein-Barr virus-associated malignancies nasopharyngeal carcinoma and Hodgkin lymphoma. Cancer Res. 64:5251-5260.
48. Mosialos, G., M. Birkenbach, R. Yalamanchili, T. VanArsdale, C. Ware, and E. Kieff. 1995. The Epstein-Barr virus transforming protein LMP1 engages signaling proteins for the tumor necrosis factor receptor family. Cell 80:389-399.
49. Munoz-Fontela, C., L. Marcos-Villar, P. Gallego, J. Arroyo, M. Da Costa, K. M. Pomeranz, E. W. Lam, and C. Rivas. 2007. Latent protein LANA2 from Kaposi's sarcoma-associated herpesvirus interacts with 14-3-3 proteins and inhibits FOXO3a transcription factor. J. Virol. 81:1511-1516.
50. Nichols, A. F., P. Ong, and S. Linn. 1996. Mutations specific to the xeroderma pigmentosum group E Ddb- phenotype. J. Biol. Chem. 271:24317-24320.
51. Nowak, M. A., N. L. Komarova, A. Sengupta, P. V. Jallepalli, M. Shih Ie, B. Vogelstein, and C. Lengauer. 2002. The role of chromosomal instability in tumor initiation. Proc. Natl. Acad. Sci. USA 99:16226- 16231.
52. O'Connell, B. C., and J. W. Harper. 2007. Ubiquitin proteasome system (UPS): what can chromatin do for you? Curr. Opin. Cell Biol. 19:206-214.
53. Philpott, S. M., and G. C. Buehring. 1999. Defective DNA repair in cells with human T-cell leukemia/bovine leukemia viruses: role of tax gene. J. Natl. Cancer Inst. 91:933-942.
54. Protic-Sabljic, M., and K. H. Kraemer. 1985. One pyrimidine dimer inactivates expression of a transfected gene in xeroderma pigmentosum cells. Proc. Natl. Acad. Sci. USA 82:6622-6626.
55. Ramaswamy, S., N. Nakamura, I. Sansal, L. Bergeron, and W. R. Sellers. 2002. A novel mechanism of gene regulation and tumor suppression by the transcription factor FKHR. Cancer Cell 2:81-91.
56. Rickinson, A. B., and E. Kieff. 2001. Epstein-Barr virus, p. 2575-2627. In D. M. Knipe and P. M. Howley (ed.), Field's virology, 4th ed., vol. 2. Lippincott/The Williams & Wilkins Co., Philadelphia, PA.
57. Saito, N., G. Courtois, A. Chiba, N. Yamamoto, T. Nitta, N. Hironaka, M. Rowe, and S. Yamaoka. 2003. Two carboxyl-terminal activation regions of Epstein-Barr virus latent membrane protein 1 activate NF-κB through distinct signaling pathways in fibroblast cell lines. J. Biol. Chem. 278:46565-46575.
58. Scholle, F., K. M. Bendt, and N. Raab-Traub. 2000. Epstein-Barr virus LMP2A transforms epithelial cells, inhibits cell differentiation, and activates Akt. J. Virol. 74:10681-10689.
59. Schrofelbauer, B., Y. Hakata, and N. R. Landau. 2007. HIV-1 Vpr fraction is mediated by interaction with the damage-specific DNA-binding protein DDB1. Proc. Natl. Acad. Sci. USA 104:4130-4135.
60. Shore, A. M., P. C. White, R. C. Hui, A. Essafi, E. W. Lam, M. Rowe, and P. Brennan. 2006. Epstein-Barr virus represses the FOXO1 transcription factor through latent membrane protein 1 and latent membrane protein 2A. J. Virol. 80:11191-11199.
61. Sitterlin, D., T. H. Lee, S. Prigent, P. Tiollais, J. S. Butel, and C. Transy. 1997. Interaction of the UV-damaged DNA-binding protein with hepatitis B virus X protein is conserved among mammalian hepadnaviruses and restricted to transactivation-proficient X-insertion mutants. J. Virol. 71:6194-6199.
62. Swart, R., I. K. Ruf, J. Sample, and R. Longnecker. 2000. Latent membrane protein 2A-mediated effects on the phosphatidylinositol 3-kinase/Akt pathway. J. Virol. 74:10838-10845.
63. Tran, H., A. Brunet, J. M. Grenier, S. R. Datta, A. J. Fornace, Jr., P. S. DiStefano, L. W. Chiang, and M. E. Greenberg. 2002. DNA repair pathway stimulated by the forkhead transcription factor FOXO3a through the Gadd45 protein. Science 296:530-534.
64. Trojanek, J., S. Croul, T. Ho, J. Y. Wang, A. Darbinyan, M. Nowicki, L. D. Valle, T. Skorski, K. Khalili, and K. Reiss. 2006. T-antigen of the human polyomavirus JC attenuates faithful DNA repair by forcing nuclear interaction between IRS-1 and Rad51. J. Cell Physiol. 206:35-46.
65. Uchida, J., T. Yasui, Y. Takaoka-Shichijo, M. Muraoka, W. Kulwichit, N. Raab-Traub, and H. Kikutani. 1999. Mimicry of CD40 signals by Epstein-Barr virus LMP1 in B lymphocyte responses. Science 286:300-303.
66. van Pelt, J. F., T. Severi, T. Crabbe, A. V. Eetveldt, C. Verslype, T. Roskams, and J. Fevery. 2004. Expression of hepatitis C virus core protein impairs DNA repair in human hepatoma cells. Cancer Lett. 209:197-205.
67. Wang, D., D. Liebowitz, and E. Kieff. 1985. An EBV membrane protein expressed in immortalized lymphocytes transforms established rodent cells. Cell 43:831-840.
68. Wilson, J. B., W. Weinberg, R. Johnson, S. Yuspa, and A. J. Levine. 1990. Expression of the BNLF-1 oncogene of Epstein-Barr virus in the skin of transgenic mice induces hyperplasia and aberrant expression of keratin 6. Cell 61:1315-1327.
69. Wittschieben, B. O., and R. D. Wood. 2003. DDB complexities. DNA Repair 2:1065-1069.